Assertio Holdings
ASRT
#9516
Rank
โ‚น6.78 B
Marketcap
โ‚น1,057
Share price
-2.83%
Change (1 day)
1,373.53%
Change (1 year)

Revenue for Assertio Holdings (ASRT)

Revenue in 2025 (TTM): โ‚น11.92 Billion

According to Assertio Holdings's latest financial reports the company's current revenue (TTM ) is โ‚น12.43 Billion. In 2024 the company made a revenue of โ‚น10.71 Billion a decrease over the revenue in the year 2023 that were of โ‚น12.65 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Assertio Holdings from 1997 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น11.92 B11.23%
2024 โ‚น10.71 B-15.32%
2023 โ‚น12.65 B-2.08%
2022 โ‚น12.92 B56.46%
2021 โ‚น8.26 B6.31%
2020 โ‚น7.77 B-52.51%
2019 โ‚น16.36 B-24.92%
2018 โ‚น21.79 B-10.32%
2017 โ‚น24.30 B-21.53%
2016 โ‚น30.98 B36.02%
2015 โ‚น22.77 B-7.94%
2014 โ‚น24.74 B198.39%
2013 โ‚น8.29 B66.74%
2012 โ‚น4.97 B-29.31%
2011 โ‚น7.03 B94.37%
2010 โ‚น3.61 B35.11%
2009 โ‚น2.67 B59.95%
2008 โ‚น1.67 B-34.93%
2007 โ‚น2.57 B508.43%
2006 โ‚น0.42 B113.39%
2005 โ‚น0.19 B
2003 โ‚น44.71 M-43.87%
2002 โ‚น79.66 M-55.06%
2001 โ‚น0.17 B113.81%
2000 โ‚น82.89 M726.74%
1999 โ‚น10.02 M-66.31%
1998 โ‚น29.76 M26.23%
1997 โ‚น23.57 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
OPKO Health
OPK
โ‚น58.12 B 367.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
โ‚น20.46 M-99.84%๐Ÿ‡บ๐Ÿ‡ธ USA